Brief: Renovorx Says On February 21, Co Got Notice From Nasdaq
23/02/2024 23:48
Feb 23 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX INC - ON FEBRUARY 21, CO GOT NOTICE FROM NASDAQ
THAT CO
HAD, AS OF DATE OF NOTICE, FAILED TO MEET MINIMUM STOCKHOLDERS'
EQUITY REQUIREMENT
Source text for Eikon: ID:n0001493152-24-007693
Further company coverage: RNXT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer